Phase1 Syudy to Evaluate the Safety and PK/PD of Human Antithrombin III
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2009-02-18
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT00846274
- Locations
- π°π·
SK chemicals, Seoul, Korea, Republic of
Phase III Trial of Febuxostat in Korea Gout Patients
- First Posted Date
- 2009-01-13
- Last Posted Date
- 2009-01-13
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 181
- Registration Number
- NCT00821392
A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine
- First Posted Date
- 2009-01-13
- Last Posted Date
- 2013-04-18
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 298
- Registration Number
- NCT00821483
Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes Mellitus
- First Posted Date
- 2008-06-26
- Last Posted Date
- 2013-04-18
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 112
- Registration Number
- NCT00705861
- Locations
- π°π·
SK Chemicals Co., Ltd, Seoul, Korea, Republic of
Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2009-01-13
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT00689858
- Locations
- π°π·
INJE University Pusan Paik Hospital, Pusan, Korea, Republic of
π°π·SK chemicals, Seoul, Korea, Republic of
π°π·SKChemicals, Seoul, Korea, Republic of
Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2013-04-18
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 109
- Registration Number
- NCT00644007
- Locations
- π°π·
SK Chemicals Co., Ltd, Seoul, Korea, Republic of
Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine
- First Posted Date
- 2008-02-29
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 13
- Registration Number
- NCT00626743
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
π°π·INJE University Pusan Paik Hospital, Pusan, Korea, Republic of
Phase I Study to Investigate the Alcohol Interaction of SK3530
Phase 1
Completed
- Conditions
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2007-06-21
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT00489450
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530
Phase 1
Completed
- Conditions
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2007-06-21
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT00489606
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Phase 1 Study of SK3530 to Investigate of the Effect of Food
Phase 1
Completed
- Conditions
- First Posted Date
- 2007-03-06
- Last Posted Date
- 2013-04-18
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT00443625
Β© Copyright 2024. All Rights Reserved by MedPath